Drugs Made In America Acquisition II Corp.
DMII- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002040475
No open-market purchases or sales by Drugs Made In America Acquisition II Corp. insiders were filed in the last 90 days; 69 institutions reported holding it in 13F filings for Q2 2026, worth $457.4M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Drugs Made In America Acquisition II Corp. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 68 | 69 | +1 |
| Shares | 43.9M | 45.5M | +1.53M (+3.5%) |
| Value | $438.1M | $457.4M | +$19.3M (+4.4%) |
New holders (6)
Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| TIG Advisors, LLC | 500,000 | $5.03M | 0.23% |
| Cantor Fitzgerald, L. P. | 363,100 | $3.65M | 0.07% |
| SkyView Investment Advisors, LLC | 250,000 | $2.52M | 1.97% |
| Kepos Capital LP | 210,000 | $2.11M | 2.88% |
| SRS Capital Advisors, Inc. | 65,990 | $663.9K | 0.00% |
| Tuttle Tactical Management | 10,769 | $108.3K | 0.07% |
Sold out (5)
Institutions that held Drugs Made In America Acquisition II Corp. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 2,000,000 | $20.0M |
| Sculptor Capital LP | 500,000 | $4.99M |
| Parallax Volatility Advisers, L.P. | 133,647 | $1.34M |
| CSS LLC | 110,042 | $1.10M |
| Mizuho Securities USA LLC | 18,600 | $184.1K |